Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Arginine N-Methyltransferases | 2 | 2024 | 41 | 0.280 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2024 | 9 | 0.240 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 190 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2021 | 61 | 0.180 |
Why?
|
| Herpesvirus 2, Gallid | 1 | 2018 | 2 | 0.160 |
Why?
|
| Marek Disease | 1 | 2018 | 2 | 0.160 |
Why?
|
| Ultracentrifugation | 1 | 2018 | 20 | 0.160 |
Why?
|
| Poultry Diseases | 1 | 2018 | 7 | 0.160 |
Why?
|
| Circulating MicroRNA | 1 | 2018 | 9 | 0.160 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 53 | 0.150 |
Why?
|
| Exosomes | 1 | 2018 | 43 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 263 | 0.150 |
Why?
|
| Population Health | 1 | 2017 | 37 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 550 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 296 | 0.130 |
Why?
|
| Genomics | 1 | 2021 | 1494 | 0.100 |
Why?
|
| Vaccines | 1 | 2017 | 369 | 0.100 |
Why?
|
| Shigella | 1 | 2012 | 3 | 0.100 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 209 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 158 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 176 | 0.090 |
Why?
|
| Neoplasms | 2 | 2024 | 2788 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2012 | 809 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3342 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2024 | 40 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1709 | 0.060 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2023 | 16 | 0.060 |
Why?
|
| Animals | 5 | 2024 | 34209 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 4432 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 173 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2023 | 441 | 0.050 |
Why?
|
| Mice | 3 | 2024 | 17751 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2024 | 372 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2021 | 19 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 112 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 263 | 0.040 |
Why?
|
| Marek Disease Vaccines | 1 | 2018 | 1 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2024 | 748 | 0.040 |
Why?
|
| Vaccine Potency | 1 | 2017 | 9 | 0.040 |
Why?
|
| Chickens | 1 | 2018 | 638 | 0.040 |
Why?
|
| Epidemics | 1 | 2017 | 54 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 1683 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1932 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2021 | 820 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 665 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 323 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2017 | 359 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2017 | 160 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2410 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 521 | 0.030 |
Why?
|
| Vaccination | 1 | 2017 | 955 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 145 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2012 | 260 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 318 | 0.020 |
Why?
|
| Virulence | 1 | 2012 | 262 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 660 | 0.020 |
Why?
|
| Humans | 4 | 2024 | 124907 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 510 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3066 | 0.020 |
Why?
|
| Female | 1 | 2024 | 66625 | 0.010 |
Why?
|